WHO Pharmaceuticals Newsletter
No. 4, 2012
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities across the world. It also provides signals from the Uppsala Monitoring Centre's SIGNAL document
The feature articles in this issue give you information of new dosage recommendations for morphine and other opioid analgesics in children. And you will also find a summary of discussions and recommendations from the ninth meeting of the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP).